Date: 2008/10/23 | Deadline: 2039/12/12 |
Organisation | FORENAP | Department | |
Contact person | GRAFF, Mrs Caroline | ||
caroline.graff@forenap.com | |||
Address | 27, rue du 4ème RSM B.P. 27 |
||
Postcode | 68250 | City | ROUFFACH |
Country | France | ||
Telephone | 0033-389-78-73-82 | Fax | |
Website | www.forenap.com |
Title: New translational strategies for cognitive dysfunction treatments of Schizophrenia | Acronym: STIGMA |
Project type | Large-scale integrating collaborative project |
Status | Planned for submission |
Call references | FP7 Call 3 |
Priorities’ Main Research Areas | Clinical trials in Psychiatry, animals models, knock-out, genetics, pharmacology, neuroimaging, pathophysiology | ||
Workprogramme Topic (according to each priority workprogramme) | |||
Project description The multidisciplinary STIGMA consortium aims are focused on new tools development enabling the Schizophrenia community to accelerate the research on mechanisms of action (MOA) and the drug development for treatments targeting cognitive dysfunction. |
|||
Keywords | Schizophrenia, cognition, treatment, clinical studies, genetics, animal models , prefrontal cortex | ||
Partners already involved | |||
Project budget (for the running projects) | nc | Budget reserved for SMEs | nc |
• HEALTH- 2009-2.2.1-3: Optimising current therapeutic approaches to schizophrenia. FP7-HEALTH-2009-single-stage. |
Role | research, training, dissemination, other |
Country /region | All european countries except France |
Start of partnership | start-up phase |
Expertise required | Request for several partners: * Expertise in all kind of disseminations (public, scientific, etc...) with various methods: organisation of workshop, meeting and writing project leaflets, posters, etc.... * Expertise in training: organising training seminaries for medical researchers and summer schools for students * Expertise in health economic studies in schizophrenia. * Expertise in psychiatry and clinical trials in patients. * Expertise in transcranial magnetic stimulation in healthy subjects, induction of cognitive dysfunctions |